Current Report · Items 5.03, 9.01 · 8-K
VSee Health, Inc.
VSEENASDAQEQUITYCurrent
Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year On September 22, 2026, VSee Health, Inc. (the “Company”) filed a Certificate of Amendment (the “Certificate of Amendment”) to the Company’s Second Amended and Restated Certificate of Incorporation, as amended, to effect a reverse stock split of its issued common stock, par value $0.0001 per share (“Common Stock”), i…
Filed Sep 23, 2026Accepted Sep 23, 2026, 4:10 PM EDTCIK 1864531Accession 0001185185-26-004244
Company context
VSee Health (NASDAQ:VSEE) is a telehealth technology and services company delivering high-acuity virtual care solutions through its scalable, API-driven platform. The Company’s offerings integrate secure video, device data, and EHR connectivity to power hospital systems, health networks, and employers across the United States. For more information, please visit vseehealth.com.
Current securities
Historical securities (3)
Disclosure sections
Items 5.03, 9.01Select an item to read the extracted section. The as-filed document remains the primary evidence.
Item 5.03Item 5.03 - Amendments to Articles/Bylaws
Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change
in Fiscal Year
On September 22, 2026, VSee Health, Inc.
(the “Company”) filed a Certificate of Amendment (the “Certificate of Amendment”) to the Company’s Second
Amended and Restated Certificate of Incorporation, as amended, to effect a reverse stock split of its issued common stock, par value $0.0001
per share (“Common Stock”), in the ratio of 1-for-80 (the “Reverse Stock Split”), which will become effective
at 5:00 p.m., eastern time, on September 23, 2026. The Common Stock will begin trading on a split-adjusted basis
at the market open on Thursday, September 24, 2026.
The Reverse Stock Split and the form
of Certificate of Amendment were previously approved by the Company’s Board of Directors and the Company’s stockholders. The
new CUSIP number for the Common Stock following the Reverse Stock Split is 92919Y 201. No fractional shares will be issued as a result
of the Reverse Stock Split. Instead, any fractional shares that would have resulted from the Reverse Stock Split will be rounded up to
the next whole number. The Reverse Stock Split affects all stockholders uniformly and will not alter any stockholder’s percentage
interest in the Company’s outstanding Common Stock, except for adjustments that may result from the treatment of fractional shares.
The number of authorized shares of Common Stock of the Company and number of authorized, issued, and outstanding shares of the preferred
stock of the Company were not changed.
The above description of the Certificate
of Amendment does not purport to be complete and is qualified in its entirety by reference to the full text of the Certificate of Amendment,
which is filed as Exhibit 3.1 to this Current Report on Form 8-K and is incorporated by reference herein.